Regeneron Pharmaceuticals, Inc.
Feb 13, 2017

Regeneron Announces Upcoming 2017 Investor Conference Presentations

TARRYTOWN, N.Y., Feb. 13, 2017 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

  • Leerink Partners 6th Annual Global Healthcare Conference at 10:30 a.m. Eastern Time on Thursday, February 16, 2017
  • Raymond James 38th Annual Institutional Investors Conference at 1:05 p.m. Eastern Time on Monday, March 6, 2017              

The sessions may be accessed through the Company's web site,, on the 'Events and Presentations' page.  Archived versions of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL cholesterol and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including rheumatoid arthritis, atopic dermatitis, asthma, pain, cancer and infectious diseases. For additional information about the company, please visit or follow @Regeneron on Twitter.

Contact Information:

Investor Relations

Corporate Communications

Manisha Narasimhan, Ph.D.

Hala Mirza




To view the original version on PR Newswire, visit:

SOURCE Regeneron Pharmaceuticals, Inc.

News Provided by Acquire Media